Price $4.09 |
Market Cap
324.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.02
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
25K
|
FCF
-3.6
|
|
Op. Margin
2.50%
|
Net Margin
-4.70%
|
ROE
36.60%
|
ROI
2.10%
|
|
ROA
-3.90%
|
EPS Growth
74.80%
|
Current Ratio
1.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $5.13 | - | - | 1.43B | Strong Buy |
| Ocugen Inc (OCGN) | $0.71 | - | - | 8.2M | Strong Buy |
| Invacare Corporation (IVC) | $8.59 | - | 0.60% | 310.6M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.70 | - | - | 14.1M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $1.24 | - | - | 96M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
